Asthma Research Unit, Glasgow University
Glasgow, Scotland, G12 0YN, United Kingdom
NCT Number: NCT00411320
Smokers with asthma display a relative insensitivity to inhaled and oral corticosteroids. The causes of this phenomenon are currently unknown. The investigators will perform a number of blood & breathing tests to try to discover the cause/s behind this phenomenon with the aim of producing leads for further investigation and possible new treatments for smokers with asthma.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Glasgow, Scotland, G12 0YN, United Kingdom
Smokers with asthma display a relative insensitivity to inhaled and oral corticosteroids. The causes of this phenomenon are currently unknown. However research into steroid resistance in severe asthma and the smoking related condition chronic obstructive pulmonary disease (COPD) points to a number of possible causes. We will characterise a group of smokers with asthma and perform a number of investigations and compare the results to ex-smokers and never smokers with asthma with the aim of establishing which previously published steroid resistance phenomena are related to the steroid resistance displayed by smokers with asthma. Results produced from this trial will provide hypothesis generating information leading to future pharmaceutical trials.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 week steroid trial
Time frame: 2 weeks
University of Glasgow
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05278065
Asthma, Behavior
Providence, Rhode Island, United States
View Trial DetailsNCT00159315
Asthma, Behavior
London, United Kingdom
View Trial DetailsNCT02596087
Actinomycetales Infections, Anemia
Boston, Massachusetts, United States
View Trial DetailsNCT02991781
Asthma, Behavior
Sofia, Bulgaria
View Trial Details